Growth Metrics

ProQR Therapeutics (PRQR) Profit After Tax Growth (1y) (2014 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 65.80%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 17.05%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -290.15%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 59.59%
7 Evaxion A 62.56 Bn 62.54 Bn - -129.68%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,228.66%
10 ProQR Therapeutics 174.11 Mn 66.54 Mn - -4.42%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -4.42%
Sep 30, 2025 -44.50%
Jun 30, 2025 -375.55%
Mar 31, 2025 -27.44%
Dec 31, 2024 -68.55%
Sep 30, 2024 -50.92%
Jun 30, 2024 66.63%
Mar 31, 2024 12.47%
Dec 31, 2023 56.52%
Sep 30, 2023 74.89%
Jun 30, 2023 39.62%
Mar 31, 2023 40.01%
Dec 31, 2022 34.97%
Sep 30, 2022 -32.22%
Jun 30, 2022 -175.84%
Mar 31, 2022 -4.10%
Dec 31, 2021 -32.30%
Sep 30, 2021 -215.35%
Jun 30, 2021 318.15%
Mar 31, 2021 -85,652.29%
Dec 31, 2020 -176.69%
Sep 30, 2020 13.57%
Jun 30, 2020 134.41%
Mar 31, 2020 -100.11%
Dec 31, 2019 238.84%
Sep 30, 2019 94.64%
Jun 30, 2019 -249.28%
Mar 31, 2019 122,867.59%
Dec 31, 2018 -211.22%
Sep 30, 2018 56,274.34%
Jun 30, 2018 -29.32%
Mar 31, 2018 17.92%
Dec 31, 2017 239.86%
Sep 30, 2017 100.11%
Jun 30, 2017 204.01%
Mar 31, 2017 100.11%
Dec 31, 2016 58.27%
Sep 30, 2016 -160,775.49%
Jun 30, 2016 -68.37%
Mar 31, 2016 -3,760.36%
Dec 31, 2015 -796.27%
Sep 30, 2015 -100.16%
Mar 31, 2015 110.10%
Dec 31, 2014 -14.47%
Sep 30, 2014 485.93%